Optimizing process characterization and scalability  by addressing purification, yield, and consistency challenges in oligonucleotide production

Understanding regulatory expectations and analytical standards and meeting evolving FDA and EMA guidelines for impurity profiling, mass spectrometry, and release testing

Addressing manufacturing bottlenecks overcoming synthesis, formulation, and stability challenges to ensure seamless transition from clinical to commercial scale